SCHEMBL7983576

SCHEMBL7983576

COc1cc2nc(Nc3c(C)cccc3Cl)c3cncn3c2cc1N1CC(C)NC(C)C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 1.00
SRC P12931 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983578 1.00 LCK (1.00) LCKSRC
SCHEMBL7981234 0.98 LCK (0.95) LCKSRC
SCHEMBL7981233 0.98 LCK (0.95) LCKSRC
SCHEMBL7987265 0.89 LCK (0.80) LCKSRC
SCHEMBL7987266 0.89 LCK (0.80) LCKSRC
SCHEMBL7986783 0.87 LCK (0.77) LCK
SCHEMBL7980086 0.85 LCK (1.00) LCKSRC
SCHEMBL7970084 0.85 LCK (1.00) LCK
SCHEMBL7969486 0.85 LCK (0.75) LCKSRC
SCHEMBL7969489 0.85 LCK (0.75) LCKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed